A Phase I and Early Efficacy Study of Convection Enhanced Delivery of Irinotecan Liposome Injection Using Real Time Imaging With Gadolinium in Children With Diffuse Intrinsic Pontine Glioma
Latest Information Update: 11 Oct 2021
At a glance
- Drugs Irinotecan (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Adverse reactions
- 06 Oct 2021 Status changed from active, no longer recruiting to completed.
- 04 Oct 2021 Planned End Date changed from 1 Sep 2021 to 1 Nov 2021.
- 04 Oct 2021 Planned primary completion date changed from 1 Sep 2020 to 1 Nov 2021.